Evidence map›Paper›PMID 40411708›Full record

ArticleJournal of physiology and biochemistry2025

Spexin peptide ameliorates renal injury in diabetic nephropathy rat model via modulation of metabolic, oxidative, inflammatory, and apoptotic dysregulations.

Hadeel Elsherbiny, Sulaiman Mohammed Alnasser, Mohamed Aref, Esraa ElSheikh, Sherein F El-Sayed, Nanees F El-Malkey, Haifa A Alqahtani, Abdullah A A Alghamdi, Mohamed A Nassan, Hanan H Abd-ELhafeez and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Emerging roles of spexin in cardiovascular homeostasis.Frontiers in cardiovascular medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hadeel ElsherbinyDepartment of Medical Physiology, Faculty of Medicine, Zagazig University, Zagazig, El-Sharkia, 44519, Egypt.
Sulaiman Mohammed AlnasserDepartment of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Qassim, 51452, Saudi Arabia.
Mohamed ArefDepartment of Anatomy and Embryology, Faculty of Veterinary Medicine, Zagazig University, El- Sharkia, 44519, Egypt.
Esraa ElSheikhDepartment of Anatomy and Embryology, Faculty of Veterinary Medicine, Zagazig University, El- Sharkia, 44519, Egypt.
Sherein F El-SayedDepartment of Medical Physiology, Faculty of Medicine, Zagazig University, Zagazig, El-Sharkia, 44519, Egypt.
Nanees F El-MalkeyDepartment of Medical Physiology, Faculty of Medicine, Zagazig University, Zagazig, El-Sharkia, 44519, Egypt.
Haifa A AlqahtaniDepartment of Biology, College of Science, Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi Arabia.
Abdullah A A AlghamdiDepartment of Biology, Faculty of Science, Al-Baha University, Al-Baha, Saudi Arabia.
Mohamed A NassanDepartment of Clinical Laboratory Sciences, Turabah University College, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia.
Hanan H Abd-ELhafeezDepartment of Cell and Tissues, Faculty of Veterinary Medicine, Assiut University, Assiut, 71526, Egypt.
Gamal A SalemDepartment of Pharmacology, Faculty of Veterinary Medicine, Zagazig University, El-Sharkia, 44519, Egypt. gamal_vet_85@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy is recognized as the predominant cause of end-stage renal disease worldwide. In reaction to metabolic stress, the peptide hormone spexin-14, is synthesized in both central and peripheral tissues. Its level is reduced in type II diabetes mellites and may play a role in glucose metabolism. However, in the context of DN, the mechanisms through which spexin exerts its effects remain largely unknown. This research employed a rat model of DN to explore the therapeutic potential and the underlying mechanisms associated with spexin treatment. For the development of this experimental model, rats were subjected to an eight-week regimen of a high-fat, high-fructose diet prior to receiving a single dose of streptozotocin (35 mg/kg body weight). Subsequently, spexin was administered subcutaneously on a daily basis for a duration of eight weeks at a dosage of 50 µg/kg body weight. The evaluation methods employed encompassed renal function assessments, macromorphological examinations, histopathological evaluations, and analyses of inflammatory and oxidative stress mediators. Additionally, immunohistochemical staining for NF-kB and E-cadherin, along with PCR analysis of mTOR, Bcl2, and Bax gene expressions in renal tissues, were conducted. Following the administration of spexin to the diabetic rats, there was a significant reduction in serum levels of glucose, urea, creatinine, and inflammatory cytokines (IL-1β, TNF-α), alongside a marked restoration of antioxidant enzyme activities. Furthermore, a significant decline in the levels of NF-κB, mTOR, and Bax was noted and accompanied with increased expressions of Bcl-2 and E-cadherin proteins. The observed improvements in histopathological changes significantly corroborated the biochemical results. In summary, spexin has proven to be effective in alleviating DN by its capacity to mitigate metabolic disturbances, oxidative stress, inflammation, and apoptosis.

Indexed as

ApoptosisDiabetes Mellitus, ExperimentalDiabetic NephropathiesKidneyPeptide HormonesAnimalsbcl-2-Associated X ProteinMaleNF-kappa BOxidative StressRatsTOR Serine-Threonine Kinasesbcl-2-Associated X ProteinNF-kappa BPeptide HormonesTOR Serine-Threonine Kinases

Identifiers

PMID40411708

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.